A breakthrough laser-based medical device to eradicate bacterial biofilm in chronic wounds and accelerate wound healing.

Project description

Safe laser device kills bacterial biofilms in chronic wounds

There are no current methods to eradicate the bacterial biofilms that form in chronic wounds, preventing faster healing for an estimated 10 million people in Europe and 6.4 million in the US. The LASER-HEAL project addresses this lack through a device that reaches deep within wounds and includes software that recognises wound terrain and helps position a laser accurately. This non-invasive technology uses a dozen half-hour treatments at EUR 1 000 per treatment, and it does not destroy skin cells. The aim is to build a clientele first through US clinics, prior to expanding to Europe and globally.

Fields of science

• natural sciences › computer and information sciences › software
• natural sciences › biological sciences › microbiology › bacteriology
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › antibiotics
• natural sciences › physical sciences › optics › laser physics

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

VULCUR MEDTECH

Net EU contribution

€ 50 000,00

Address

Sondervigvej 50
Vanlose
Denmark

Region

Danmark › Hovedstaden › Byen København

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 21 429,00